REFERENCES
- Gaynon P S, Lustig R H. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations. J Pediatr Hematol Oncol.. 1995; 17: 1–12. [PUBMED], [INFOTRIEVE]
- Gaynon P S, Carrel A L. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol.. 1999; 457: 593–605. [PUBMED], [INFOTRIEVE]
- Jones B, Freeman A I, Shuster J J, et al, Lower incidence of meningeal leukaemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol.. 1991; 19: 269–275. [PUBMED], [INFOTRIEVE]
- Kamps W A, Veerman A J, van Wering E R, et al, Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991. Leukemia. 2000; 14: 2240–2246. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gaynon P S, Trigg M E, Heerema N A, et al, Children's Cancer Group trials in childhood acute lymphoblastic leukemia. 1983–1995. Leukemia.. 2000; 14: 2223–2233. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bostrom B, Gaynon P S, Sather H, et al, Dexamethasone (Dex) decreases central nervous system (CNS) relapse and improves event-free survival in lower risk acute lymphoblastic leukemia. Proc Am Soc Clin Oncol.. 1998; 17: 527a
- Gaynon P S. Response to Donadieu and Hill Clinical trials in childhood acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are now warranted. J Pediatr Hematol Oncol.. 2002; 24: 426–428. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Pui C H, Evans W E. Acute lymphoblastic leukemia. N Engl J Med.. 1998; 339: 605–615. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Pui C H, Mahmoud H H, Rivera G K, et al, Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood. 1998; 92: 411–415. [PUBMED], [INFOTRIEVE]
- Conter V, Arico M, Valsecchi M G, et al, Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. J Clin Oncol.. 1995; 13: 2497–2502. [PUBMED], [INFOTRIEVE]
- Gomez-Almaguer D, Gonzalez-Llano O, Montemayor J, et al, Dexamethasone in the treatment of meningeal leukemia. Am J Hematol.. 1995; 49: 353–354. [PUBMED], [INFOTRIEVE]
- Balis F M, Lester C M, Chrousos G P, et al, Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol.. 1987; 5: 202–207. [PUBMED], [INFOTRIEVE]
- Riehm H, Feickert H J, Schrappe M, et al, Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis. Haematol Blood Transfus.. 1987; 30: 139–146. [PUBMED], [INFOTRIEVE]
- Riehm H, Gadner H, Henze G, et al, Results and significance of six randomized trials in four consecutive ALL-BFM trials. Hamatol Bluttransfus. 1990; 33: 439–450
- Reiter A, Schrappe M, Ludwig W D, et al, Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM Group. Blood.. 1992; 80: 2471–2478. [PUBMED], [INFOTRIEVE]
- Reiter A, Schrappe M, Ludwig W D, et al, Chemotherapy in 998 unselected childhood acute lymphoblastic leukaemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994; 84: 3122–3133. [PUBMED], [INFOTRIEVE]
- Schrappe M, Reiter A, Ludwig W D, et al, Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000; 95: 3310–3322. [PUBMED], [INFOTRIEVE]
- Conter V, Arico M, Valsecchi M G, et al, Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982–1995. Leukemia. 2000; 14: 2196–2204. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Riehm H, Reiter A, Schrappe M. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr. 1987; 199: 151–160. [PUBMED], [INFOTRIEVE]
- Schrappe M, Reiter A, Sauter S, et al, Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow. Klin Padiatr. 1994; 206: 208–221. [PUBMED], [INFOTRIEVE]
- Schrappe M, Arico M, Harbott J, et al, Philadelphia chromosome positive (Ph+) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome. Blood. 1998; 92: 2730–2741. [PUBMED], [INFOTRIEVE]
- Arico M, Basso G, Mandelli F, et al, Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. Cancer. 1995; 75: 1684–1693. [PUBMED], [INFOTRIEVE]
- Veerman A J, Hahlen K, Kamps W A, et al, High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol.. 1996; 14: 911–918. [PUBMED], [INFOTRIEVE]
- Winick N, Shuster J J, Bowman W P, et al, Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol.. 1996; 14: 2803–2811. [PUBMED], [INFOTRIEVE]
- Schrappe M, Beck J, Brandeis W E, et al, Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81. Klin Padiatr.. 1987; 199: 133–150. [PUBMED], [INFOTRIEVE]
- Riehm H, Reiter A, Schrappe M, et al, Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr.. 1987; 199: 151–160. [PUBMED], [INFOTRIEVE]
- Boissel N, Auclerc M F, Lheritier V, et al, Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol.. 2003; 21: 774–780. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Vilmer E, Suciu S, Ferster A, et al, Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia. 2000; 14: 2257–2266. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schwartz C L, Thompson E B, Gelber R D, et al, Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. J Clin Oncol.. 2001; 19: 1040–1046. [PUBMED], [INFOTRIEVE]
- Hurwitz C A, Silverman L B, Schorin M A, et al, Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer.. 2000; 88: 1964–1969. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Waber D P, Carpentieri S C, Klar N, et al, Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol.. 2000; 22: 206–213. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Levien M G. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. Clin Pediatr.. 2002; 41: 63–64
- Slavc I, Urban C, Schwingshandl J, et al, Aseptic bone necroses as a late complication following successful treatment of leukemias and severe aplastic anemia. Klin Padiatr. 1987; 199: 449–452. [PUBMED], [INFOTRIEVE]
- Kaspers G J, Veerman A J, Popp-Snijders C, et al, Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol.. 1996; 27: 114–121. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Meikle A W, Tyler F H. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med.. 1977; 63: 200–207. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kontoyiannis D P, Vaziri I, Hanna H A, et al, Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis.. 2001; 33: 1676–1681. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Flynn P M, Marina N M, Rivera G K, et al, Candida tropicalis infections in children with leukemia. Leuk Lymphoma. 1993; 10: 369–376. [PUBMED], [INFOTRIEVE]
- Martino P, Girmenia C, Micozzi A, et al, Fungemia in patients with leukaemia. Am J Med Sci.. 1993; 306: 225–232. [PUBMED], [INFOTRIEVE]
- Sotman S B, Schimpff S C, Young V M. Staphylococcus aureus bacteremia in patients with acute leukemia. Am J Med.. 1980; 69: 814–818. [PUBMED], [INFOTRIEVE]
- Miser J S, Miser A W. Staphylococcus aureus sepsis in childhood malignancy. Am J Dis Child.. 1980; 134: 831–833. [PUBMED], [INFOTRIEVE]
- Ladisch S, Pizzo P A. Staphylococcus aureus sepsis in children with cancer. Pediatrics. 1978; 61: 231–234. [PUBMED], [INFOTRIEVE]
- Lowy F D. Staphylococcus aureus infections. N Engl J Med.. 1998; 339: 520–532. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gonzalez-Barca E, Carratala J, Mykietiuk A, et al, Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis.. 2001; 20: 117–119. [CROSSREF], [PUBMED], [INFOTRIEVE]